Condensed Statements of Comprehensive Loss - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Statements of Comprehensive Loss [Abstract]
Sales	$ 271,140	$ 293,984
Cost of sales (excluding depreciation expense)	88,532	105,120
Operating expenses:
Research and development	1,770,731	1,537,439
Sales and marketing	300,487	244,896
General and administrative	1,502,804	1,315,137
Depreciation and amortization	71,228	133,066
Total operating expenses	3,645,250	3,230,538
Loss from operations	(3,462,642)	(3,041,674)
Other income (expense):
Interest income	224,684	97,089
Interest expense	(361,552)	(1,672)
Total other income (expense)	(136,868)	95,417
Net loss	(3,599,510)	(2,946,257)
Net loss attributable to common stockholders, basic	(3,599,510)	(2,946,257)
Net loss attributable to common stockholders, diluted	$ (3,599,510)	$ (2,946,257)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.17)	$ (0.25)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.17)	$ (0.25)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	21,775,357	11,872,255
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	21,775,357	11,872,255